Gerpac 2022 multimedia support Contest : Public’s choice

Find out more

2021 Conference

Future for the pharmaceutical technologies in hospital pharmacy

P. Odou (Lille, France)
T. Schnor (Herlev, Denmark)
T. Briot (Lyon, France)
I. Kramer (Mainz, Germany)
P. Le Brun (Leiden, The Netherland)
S. Crauste-Manciet (Bordeaux, France)

RNA-based vaccines

F. Lagarce (Angers - France)
D. Parsons (Cambridge (MA) - USA)
D. Brossard (Paris - France)
V. Sautou (Clermont Ferrand - France)

Find out more

2020 Conference

To view the videos of 2020 conference, you must be a GERPAC member.

Find out more

Video Award 2019

Accuracy in pharmaceutical technology
Anne Flore Dumas and her team at University Hospital Grenoble

Dumas vidéos

Find out more

2019 Conference


Carcinogens in hospitals: identification, construction of limit values and prevention of exposures
M El Yamani,
Département santé environnement travail, Santé Publique France

Exposure of healthcare workers to cytotoxic drugs
S. N’Daw, D. Flavien, M. Philippe, H. Ogier, R. Alain
Institut National de Recherche et de Sécurité (INRS), Département Polluants et santé, rue du Morvan, CS 60027, 54519 VANDOEUVRE LES NANCY Cedex, France.
1. Pharmacie à Usage Intérieur, département conception, fabrication et contrôle du médicament, CHU Amiens- Picardie, Amiens, France.
2. Laboratoire AGIR EA 4294, Université de Picardie Jules Verne, Amiens, France



Best preparation practices: international convergence and divergence
S. Crauste-Manciet, University Hospital Bordeaux, France
V. Salomon, Agence Nationale de Sécurité du Médicament et des produits de santé, France
F. Sadeghipour, CHUV Lausanne, Switzerland
J-F. Bussières, University Hospital Montréal, Canada
A. Beaney, North Tees and Hartlepool NHS Foundation Trust, UK
P. Le Brun, Leiden University Medical Center, The Netherlands
P. Kienle, Cardinal Health Pennsylvanie, USA


Microbiological stability consensus Working group
Working group:
Prof. Sylvie Crauste-Manciet, France - Prof. Irene Krämer, Germany - Prof. Frederic Lagarce, France - Prof. Valerie Sautou, France - Dr Alison Beaney, UK - Dr Julian Smith, UK - Mr V’Iain Fenton-May, UK - Prof. Jean-Daniel Hecq, Belgium - Prof. Farshid Sadeghipour, Switzerland - Dr Paul Le Brun, The Netherlands



Formulation and stability study of low-dose midazolam capsules for clinical trial
P.N. Boivin1, A.C. Bonnaure1, M.A. Lester1
1 Pharmacy department, Rennes University Hospital, Rennes, France

Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers
Marine Roche1,2, MSc, PharmD ; Damien Lannoy1,2, Ph.D., PharmD ; Florence Bourdon1, Ph.D., PharmD ; Cécile Danel2, Ph.D. ; Pierre Labalette3, Ph.D., MD ; Christophe Berneron1, PharmD ; Nicolas Simon1,2, Ph.D. PharmD ; Pascal Odou1,2, Ph.D., PharmD.
1 CHU Lille, Institut de Pharmacie, F-59000 Lille, France
2 Univ. Lille, EA 7365—GRITA—Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France

Rapid microbiological sterility test for cytotoxic batch control: is drug complexation effective for restoring microbiological growth?
Sangnier Maïté1, Bouguéon Guillaume1,2, Dubois Véronique3,4, Crauste-Manciet Sylvie1,2
(1) Pharmaceutical Technology Department, Bordeaux university hospital (CHU de Bordeaux), France
(2) ARNA Laboratory-ChemBioPharm U1212 INSERM - UMR5320, CNRS - University of Bordeaux, France
(3) Fundamental Microbiology and Pathogenicity Laboratory UMR-CNRS 5234 – University of Bordeaux, France
(4) Microbiology department, Bordeaux university hospital (CHU de Bordeaux), France

Fecal microbiota transplantation: from the raw material to the pharmaceutical preparation
R.BATISTA, Service de pharmacie, Hôpitaux Universitaires Paris Centre, Assistance Publique – Hôpitaux de Paris

Theranostics and radiopharmacy: a technical example of neuroendocrine tumour management (Gallium-68 ; Lutetium 177)
F. Debordeaux,
Nuclear medicine department, University Hospital Bordeaux

Man to Mars with an artificial ecosystem
C. Lasseur, European Space Agency & Partenaires MELiSSA

Find out more

2018 Conference


Paediatric formulations provided by hospital pharmacies
Dr Andy Lowey
Lead Clinician - Clinical Pharmacy & Preparative Services, Leeds Teaching Hospitals NHS Trust, UK

Research in the field of paediatric drug formulation
Dr F. Marçon1,2
1. Pharmacie à Usage Intérieur, département conception, fabrication et contrôle du médicament, CHU Amiens- Picardie, Amiens, France.
2. Laboratoire AGIR EA 4294, Université de Picardie Jules Verne, Amiens, France

The PaedForm project
Minna (Kuopio University Hospital, Kuopio, Finland)



Advanced Therapy Medicinal Products (ATMPs)
Moderator: Pr S. Crauste-Manciet, CHU Bordeaux

Dr L. Escalup, Institut Curie, Paris, France
Pr P. Odou, CHRU Lille, France
Dr I. Madelaine, CHU Saint-Louis, Paris, France
Dr A. Black, Hôpital Newcastle, UK
Dr C. Bernard, CHU Pitié-Salpêtrière, Paris, France



Nanoemulsion for Magnetic Hyperthermia in Oncology
H. Mazaré1, G. Prévot1, S. Mornet2, O. Sandre4,F. Couillaut 3, S. Crauste-Manciet1
1 ARNA laboratory, Univ. Bordeaux, INSERM, U1212, CNRS, UMR 5320, F-33000 Bordeaux, France
2 ICMCB, Univ. Bordeaux, CNRS, UPR 9048, F-33600 Pessac, France
3 IMOTION, EA 7435, Univ. Bordeaux, F-33000 Bordeaux, France
4 LCPO, Univ. Bordeaux, INP-ENSCBP, CNRS, UMR 5629, F-33607 Pessac, France

Microbiological stability of hydrochlorothiazide and spironolactone oral suspension coumpounded with additives-free suspending vehicule
C. Sanchez 1, K. Beuzit1, A. Bousseau2, A. Dupuis 1-3,F. G. Binson 1-3
1 Pharmacy, Poitiers Teaching Hospital, Poitiers, France
2 Hygiene unit, Poitiers Teaching Hospital, Poitiers, France
3 INSERM cic 1402 hedex, University of Poitiers, Poitiers, France

Pharmaceutical Technology: Imperatives and Opportunities
Alexander T. Florence
UCL School of Pharmacy, University College London, London WC1N, UK

Pilot Study Evaluating the Efficacy of Four Cleaning Solutions and Two Types of Mops in Delimited Areas of a Floor Contaminated with Cyclophosphamide
Roland C1, Adé A1, Ouellette-Frève JF2, Caron N3, Bussières JF1,4

1 Pharmacy Practice Research Unit, CHU Sainte-Justine, Montréal, Québec, Canada
2 Oncology Pharmacy Department, CHU Sainte-Justine, Montréal, Québec, Canada
3 Quebec Toxicology Center, Institut national de santé publique du Québec, Québec, Québec, Canada
4 Faculty of Pharmacy, Montréal University, Montréal, Québec, Canada

Particulate contamination of solutions
Pr P. Odou
GRITA - Faculty of Pharmacy – Lille University and Hospital University of Lille

Terrorist chemical threat: research and operational countermeasures
Christophe Piérard, PhD, HDR
Unité Vésicants – Département Toxicologie et Risques Chimiques
Institut de Recherche Biomédicale des Armées
B.P. 73 – 91223 Brétigny-sur-Orge Cedex, France



Development of a unit dose drug distribution robot project in a GHT
H. Bontemps, M. Boudelin
GHT Rhône Nord Beaujolais Dombes Beaujolais

Automation of dose preparation to be administered, what solutions for which objectives ?
J. Duceau
Assistant pharmacist, CHR Orléans

Find out more


Interviews with speakers and participants at our scientific days

- Richard BATEMAN, Q.A.S.Ph, Newcastle - UNITED KINGDOM

- Alison BEANEY, R.Q.A.Sp – Newcastle – UNITED KINGDOM

- Philip CHENNELL, CHU Clermont-Ferrand – FRANCE

- Thomas CONNOR, National Institute For Occupational Safety and Heath – Cincinnati - USA

- Julia GILMARTIN, University College - London – UNITED KINGDOM

- Laurence GOLDBERG, Press Consultant Pharmacist at Laurence A Goldberg Ltd Tottington Greater Manchester - UNITED KINGDOM

- Pr Irène KRAMER, University Medical center – Mainz – GERMANY

- Carmen LOPEZ – CABEZAS, Hôpital Clinic Barcelona – Barcelona – SPAIN

- Ana Maria MARTIN de ROSALES, Foundation University Hospital – Alcorcon – SPAIN

- Dr Rudolf SCHIERL, Institute for Occupationnal Social and Environmental Medicine University Hospital Munich Campus Innenstadt, Munich - GERMANY

- Julian SMITH, Meridian Pharma. Ltd, Cardiff (Walles) - UNITED KINGDON

Find out more

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data
Réalisation : Développeur web WordPress & SPIP freelance